AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35162603 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (aged 23 years)
Number of subjects: 100
Study 35162603 — intervention group
Group type: COMPARATOR
Intervention: Group A (aged 19 years)
Number of subjects: 100
Study 35162603 — intervention group
Group type: COMPARATOR
Intervention: Group A
Number of subjects: 100
Study 35162603 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 100
Study 33985884 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Humidified Oxygen (HFHO)
Number of subjects: 28
Study 33985884 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 28
Study 32103161 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor milk programs in levels 3 and 4 neonatal care facilities
Number of subjects: 120
Study 32103161 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor milk programs in level 2 neonatal care facilities
Number of subjects: 120
Study 32103161 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional prevalence of donor milk programs
Number of subjects: 120
Study 32103161 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety-net vs. non-safety-net hospitals
Number of subjects: 120
Study 35028628 — intervention group
Group type: EXPERIMENTAL
Intervention: pyronaridine‐artesunate plus primaquine
Number of subjects: 100
Study 35028628 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin‐piperaquine plus primaquine
Number of subjects: 100
Study 35028628 — intervention group
Group type: COMPARATOR
Intervention: pyronaridine‐artesunate
Number of subjects: 100
Study 35028628 — intervention group
Group type: COMPARATOR
Intervention: dihydroartemisinin‐piperaquine
Number of subjects: 100
Study 33658605 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 60
Study 33658605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32560689 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised care and support planning (CSP)
Number of subjects: 1620
Study 32560689 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes care (Control)
Number of subjects: 1620
Study 34500485 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic remedies (Arsenicum album, Bryonia alba, Gelsemium sempervirens, Pulsatilla nigricans, Hepar sulphuricus, Magnesia muriaticum, Phosphorus, Nux vomica, Belladonna)
Number of subjects: 1445
Study 34500485 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of doctors, regular monitoring of data, checking of all pre-defined symptoms, multicenter data collection
Number of subjects: 1445
Study 33487180 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic epitympanic exploration
Number of subjects: 76
Study 33487180 — intervention group
Group type: COMPARATOR
Intervention: Conventional canal wall up (cortical) mastoidectomy
Number of subjects: 76
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey-white matter differentiation (GWR) reported by radiologist
Number of subjects: 427
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: GWR stratified 1-year survival
Number of subjects: 427
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: APACHE IV score
Number of subjects: 427
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral Performance Categories at discharge and 90-day follow-up
Number of subjects: 427
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasgow Coma Scale at discharge
Number of subjects: 427
Study 35378224 — intervention group
Group type: EXPERIMENTAL
Intervention: RAND-36 stratified by normal versus abnormal GWR
Number of subjects: 427
Study 32842188 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmicort respulas immersed nasopore
Number of subjects: 30
Study 32842188 — intervention group
Group type: COMPARATOR
Intervention: Saline immersed nasopore (Control)
Number of subjects: 30
Study 34210731 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for PTSD (CT-PTSD)
Number of subjects: 120
Study 34210731 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120
Study 32659874 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (TMS) for MDD
Number of subjects: 118
Study 35144944 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) home-visiting programme
Number of subjects: 1618
Study 35144944 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 1618
Study 34529043 — intervention group
Group type: EXPERIMENTAL
Intervention: IABP-SHOCK II score
Number of subjects: 1055
Study 34529043 — intervention group
Group type: EXPERIMENTAL
Intervention: CardShock score
Number of subjects: 1055
Study 34529043 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPS II score
Number of subjects: 1055
Study 34529043 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAI classification
Number of subjects: 1055
Study 32735580 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference model embedding a realistic human connectome
Number of subjects: 0
Study 32735580 — intervention group
Group type: COMPARATOR
Intervention: Randomised connectome ensembles
Number of subjects: 0
Study 35038990 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives with a monthly stipend and training from an intercultural broker in intervention communities.
Number of subjects: 872
Study 35038990 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities.
Number of subjects: 872
Study 35038990 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities during institutional childbirths.
Number of subjects: 872
Study 35038990 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives in intervention communities during home-based childbirths.
Number of subjects: 872
Study 33846503 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐MCT (Metacognitive Training for Depression)
Number of subjects: 84
Study 33846503 — intervention group
Group type: COMPARATOR
Intervention: MyBrainTraining (Cognitive Remediation Training)
Number of subjects: 84
Study 35222584 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (group A, n=35)
Number of subjects: 60
Study 35222584 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise intervention (group B, n=35)
Number of subjects: 60
Study 35222584 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Aerobic and Resistance exercise
Number of subjects: 60
Study 32006099 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight lunges with blood-flow restriction (occlusion set at 130% of systolic blood pressure)
Number of subjects: 18
Study 32006099 — intervention group
Group type: COMPARATOR
Intervention: Body-weight lunges without blood-flow restriction
Number of subjects: 18
Study 34961732 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3987
Study 34961732 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3987
Study 33211063 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks) + Bevacizumab (15 mg/kg IV every 3 weeks) + Oral Cyclophosphamide (50 mg once daily)
Number of subjects: 40
Study 35236394 — intervention group
Group type: EXPERIMENTAL
Intervention: Release of Wolbachia-infected Aedes aegypti mosquitoes
Number of subjects: 3480
Study 35236394 — intervention group
Group type: COMPARATOR
Intervention: No release of Wolbachia-infected Aedes aegypti mosquitoes (control)
Number of subjects: 3480
Study 33724898 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation (SHR) app
Number of subjects: 72
Study 33724898 — intervention group
Group type: COMPARATOR
Intervention: Background audio (BA) app (Android)
Number of subjects: 72
Study 33724898 — intervention group
Group type: COMPARATOR
Intervention: Background audio (BA) app (iOS)
Number of subjects: 72
Study 34363315 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional printed models (3DP)
Number of subjects: 63
Study 34363315 — intervention group
Group type: COMPARATOR
Intervention: Plastinated specimens
Number of subjects: 63
Study 34842924 — intervention group
Group type: EXPERIMENTAL
Intervention: CP plus ST
Number of subjects: 487
Study 34842924 — intervention group
Group type: COMPARATOR
Intervention: ST alone
Number of subjects: 487
Study 35926990 — intervention group
Group type: EXPERIMENTAL
Intervention: PA coaching intervention underpinned by motivational interviewing and cognitive‐behavioural therapy
Number of subjects: 18
Study 35926990 — intervention group
Group type: EXPERIMENTAL
Intervention: PA coaching intervention
Number of subjects: 18
Study 34473215 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg IV 60 minutes before anesthesia)
Number of subjects: 192
Study 34473215 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL IV normal saline 60 minutes before anesthesia)
Number of subjects: 192
Study 35763437 — intervention group
Group type: EXPERIMENTAL
Intervention: Snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract combination serum (SCGS)
Number of subjects: 66
Study 35763437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 35763437 — intervention group
Group type: EXPERIMENTAL
Intervention: Snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract combination serum (SCGS) with concurrent acne treatments
Number of subjects: 66
Study 35065722 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support plus care as usual
Number of subjects: 590
Study 35065722 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 590
Study 33653406 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated community and primary healthcare worker intervention involving an anti-stigma campaign and a mobile-technology-based electronic decision support system.
Number of subjects: 133
Study 36154349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBG) 400 mg administered 15 min prior to the trial and after 5 h
Number of subjects: 12
Study 36154349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36154349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBG)
Number of subjects: 12
Study 32130172 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based glucose-monitoring and feedback system
Number of subjects: 247
Study 32130172 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard outpatient care)
Number of subjects: 247
Study 35618329 — intervention group
Group type: EXPERIMENTAL
Intervention: Upa Yoga intervention
Number of subjects: 0
Study 35618329 — intervention group
Group type: COMPARATOR
Intervention: Advice-only control group
Number of subjects: 0
Study 32712683 — intervention group
Group type: EXPERIMENTAL
Intervention: ARIF (arthroscopic reduction and internal fixation)
Number of subjects: 40
Study 32712683 — intervention group
Group type: COMPARATOR
Intervention: ORIF (open reduction internal fixation)
Number of subjects: 40
Study 35863812 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 24
Study 35863812 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 24
Study 34310725 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Engagement (ENG)
Number of subjects: 120
Study 34310725 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced Retrieval Practice (SRP)
Number of subjects: 120
Study 34310725 — intervention group
Group type: COMPARATOR
Intervention: No Active Engagement (no ENG)
Number of subjects: 120
Study 34310725 — intervention group
Group type: COMPARATOR
Intervention: No Spaced Retrieval Practice (no SRP)
Number of subjects: 120
Study 32153301 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleuralvent™ device
Number of subjects: 126
Study 32153301 — intervention group
Group type: COMPARATOR
Intervention: Chest tube insertion (16F)
Number of subjects: 126
Study 34669044 — intervention group
Group type: EXPERIMENTAL
Intervention: LIGHT session (50% of maximal knee-extension strength)
Number of subjects: 16
Study 34669044 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAVY session (≥80% maximal knee-extension strength)
Number of subjects: 16
Study 32794404 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCUS (+) HPV (+) patients
Number of subjects: 200
Study 32794404 — intervention group
Group type: COMPARATOR
Intervention: Control group (ASCUS (−))
Number of subjects: 200
Study 32794404 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCUS (−) or ASCUS (+) HPV (−) patients
Number of subjects: 200
Study 32794404 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCUS (+) HPV (−) patients
Number of subjects: 200
Study 32347624 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone plus sulforaphane
Number of subjects: 60
Study 32347624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 36072608 — intervention group
Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 100/62.5/25 mcg
Number of subjects: 1810
Study 36072608 — intervention group
Group type: COMPARATOR
Intervention: BUD/FOR 400/12 mcg
Number of subjects: 1810
Study 35849886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led medication self-management intervention
Number of subjects: 136
Study 35849886 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 136
Study 33724597 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel cluster definitions and min(p) method for fMRI data analysis
Number of subjects: 0
Study 33724597 — intervention group
Group type: COMPARATOR
Intervention: Existing fMRI analysis methods
Number of subjects: 0
Study 32348036 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (administered intravenously or subcutaneously)
Number of subjects: 0
Study 32348036 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (various products and formulations administered as single subcutaneous doses)
Number of subjects: 0
Study 32348036 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (administered as fast versus slow subcutaneous injections)
Number of subjects: 0
Study 32348036 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group in randomized, double-blind studies)
Number of subjects: 0
Study 34717551 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 218
Study 34717551 — intervention group
Group type: COMPARATOR
Intervention: Regional anesthesia
Number of subjects: 218
Study 34717551 — intervention group
Group type: COMPARATOR
Intervention: Regional anesthesia with sedation
Number of subjects: 218
Study 34717551 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased postoperative pain intensity (measured by visual analogue scale)
Number of subjects: 218
Study 32472880 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Balloon Compression (PBC)
Number of subjects: 60
Study 32472880 — intervention group
Group type: COMPARATOR
Intervention: Microvascular Decompression (MVD)
Number of subjects: 60
Study 35366640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilobradine
Number of subjects: 367
Study 35366640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 33892117 — intervention group
Group type: EXPERIMENTAL
Intervention: Healicoil Regenesorb (PLGA/ß‐TCP/Calcium Sulfate)
Number of subjects: 64
Study 33892117 — intervention group
Group type: COMPARATOR
Intervention: Twinfix Ultra HA (PLLA/HA)
Number of subjects: 64
Study 32641706 — intervention group
Group type: COMPARATOR
Intervention: 50 Hz tACS applied to the left cerebellum
Number of subjects: 15
Study 35579025 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture with standard of care (SOC)
Number of subjects: 72
Study 35579025 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure with SOC
Number of subjects: 72
Study 35579025 — intervention group
Group type: COMPARATOR
Intervention: SOC only
Number of subjects: 72
Study 35579025 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 72
Study 35579025 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 72
Study 34670534 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery followed by PRP application (Group B)
Number of subjects: 0
Study 34670534 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage of the sinus cavity followed by application of PRP (Group C)
Number of subjects: 0
Study 34670534 — intervention group
Group type: COMPARATOR
Intervention: Open surgery and moist dressings (Group A)
Number of subjects: 0
Study 32344167 — intervention group
Group type: EXPERIMENTAL
Intervention: Umifenovir
Number of subjects: 81
Study 32344167 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study 35564926 — intervention group
Group type: EXPERIMENTAL
Intervention: app‐based ABC games
Number of subjects: 86
Study 35564926 — intervention group
Group type: COMPARATOR
Intervention: Tetris
Number of subjects: 86
Study 35564926 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 86
Study 34250712 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined IPL/fractional Er:YAG treatment
Number of subjects: 0
Study 34250712 — intervention group
Group type: COMPARATOR
Intervention: Fractional Er:YAG laser treatment
Number of subjects: 0
Study 34250712 — intervention group
Group type: COMPARATOR
Intervention: Untreated control sites
Number of subjects: 0
Study 32562272 — intervention group
Group type: EXPERIMENTAL
Intervention: CC corn-based diet
Number of subjects: 72
Study 32562272 — intervention group
Group type: EXPERIMENTAL
Intervention: BT corn-based diet
Number of subjects: 72
Study 32562272 — intervention group
Group type: COMPARATOR
Intervention: CT corn-based diet
Number of subjects: 72
Study 35775679 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (Group M)
Number of subjects: 64
Study 35775679 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy (Group A)
Number of subjects: 64
Study 35775679 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment responders (Group MR)
Number of subjects: 64
Study 32925688 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients under age 75
Number of subjects: 88988
Study 32925688 — intervention group
Group type: COMPARATOR
Intervention: Patients aged 75 and older
Number of subjects: 88988
Study 32754804 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum immunotherapy (recombinant GAD65 conjugated to aluminium hydroxide)
Number of subjects: 0
Study 32754804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36286272 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0
Study 36286272 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study 32017413 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage with a warm hand bath
Number of subjects: 28
Study 35471153 — intervention group
Group type: EXPERIMENTAL
Intervention: Olipudase alfa
Number of subjects: 36
Study 35471153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35471153 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 34518408 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form Cohen-Mansfield Agitation Inventory (CMAI)
Number of subjects: 553
Study 34518408 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form CMAI
Number of subjects: 553
Study 36412106 — intervention group
Group type: EXPERIMENTAL
Intervention: Message emphasising the effect of alcohol on the immune system
Number of subjects: 953
Study 36412106 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 953
Study 36412106 — intervention group
Group type: EXPERIMENTAL
Intervention: Message emphasising the effect of alcohol on mental health
Number of subjects: 953
Study 36412106 — intervention group
Group type: EXPERIMENTAL
Intervention: Message emphasising the effect of alcohol on physical health
Number of subjects: 953
Study 32004998 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg d-cycloserine (DCS)
Number of subjects: 53
Study 32004998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 35651892 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation group (TeleGr)
Number of subjects: 34
Study 35651892 — intervention group
Group type: COMPARATOR
Intervention: Control group (CGr)
Number of subjects: 34
Study 34792483 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (pPCI)
Number of subjects: 151
Study 34792483 — intervention group
Group type: COMPARATOR
Intervention: Staged PCI
Number of subjects: 151
Study 33340878 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg hydrocortisone
Number of subjects: 48
Study 33340878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 35879804 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release carvedilol-IR
Number of subjects: 0
Study 35879804 — intervention group
Group type: COMPARATOR
Intervention: SLOW release carvedilol-SR
Number of subjects: 0
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scores (PRS)
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: Long Life Family Study (LLFS)
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: FamHS-High Risk
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS*FamHS-High Risk
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex-specific association
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS*Sex
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS quartile distributions
Number of subjects: 8
Study 33844929 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS quartile results
Number of subjects: 8
Study 33517740 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic Alignment (KA)
Number of subjects: 138
Study 33517740 — intervention group
Group type: COMPARATOR
Intervention: Mechanical Alignment (MA)
Number of subjects: 138
Study 34971920 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) administration
Number of subjects: 0
Study 34567787 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks combined centre-based+mHealth home-based CR
Number of subjects: 132